IBDEI128 ; ; 20-MAY-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;OCT 15, 2014
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,18893,2)
 ;;=^340622
 ;;^UTILITY(U,$J,358.3,18894,0)
 ;;=V65.19^^104^1102^45
 ;;^UTILITY(U,$J,358.3,18894,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,18894,1,2,0)
 ;;=2^V65.19
 ;;^UTILITY(U,$J,358.3,18894,1,5,0)
 ;;=5^Person Consulting on Behalf of Pt
 ;;^UTILITY(U,$J,358.3,18894,2)
 ;;=^329985
 ;;^UTILITY(U,$J,358.3,18895,0)
 ;;=V66.7^^104^1102^5
 ;;^UTILITY(U,$J,358.3,18895,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,18895,1,2,0)
 ;;=2^V66.7
 ;;^UTILITY(U,$J,358.3,18895,1,5,0)
 ;;=5^Encounter for Palliative Care
 ;;^UTILITY(U,$J,358.3,18895,2)
 ;;=^89209
 ;;^UTILITY(U,$J,358.3,18896,0)
 ;;=V11.4^^104^1102^18
 ;;^UTILITY(U,$J,358.3,18896,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,18896,1,2,0)
 ;;=2^V11.4
 ;;^UTILITY(U,$J,358.3,18896,1,5,0)
 ;;=5^Hx Combat/Operational Stress
 ;;^UTILITY(U,$J,358.3,18896,2)
 ;;=^339674
 ;;^UTILITY(U,$J,358.3,18897,0)
 ;;=V60.1^^104^1102^20
 ;;^UTILITY(U,$J,358.3,18897,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,18897,1,2,0)
 ;;=2^V60.1
 ;;^UTILITY(U,$J,358.3,18897,1,5,0)
 ;;=5^Inadequate Housing
 ;;^UTILITY(U,$J,358.3,18897,2)
 ;;=^295540
 ;;^UTILITY(U,$J,358.3,18898,0)
 ;;=V62.84^^104^1102^49
 ;;^UTILITY(U,$J,358.3,18898,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,18898,1,2,0)
 ;;=2^V62.84
 ;;^UTILITY(U,$J,358.3,18898,1,5,0)
 ;;=5^Suicidal Ideation
 ;;^UTILITY(U,$J,358.3,18898,2)
 ;;=^332876
 ;;^UTILITY(U,$J,358.3,18899,0)
 ;;=V62.85^^104^1102^16
 ;;^UTILITY(U,$J,358.3,18899,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,18899,1,2,0)
 ;;=2^V62.85
 ;;^UTILITY(U,$J,358.3,18899,1,5,0)
 ;;=5^Homicidal Ideation
 ;;^UTILITY(U,$J,358.3,18899,2)
 ;;=^339690
 ;;^UTILITY(U,$J,358.3,18900,0)
 ;;=V58.61^^104^1102^23
 ;;^UTILITY(U,$J,358.3,18900,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,18900,1,2,0)
 ;;=2^V58.61
 ;;^UTILITY(U,$J,358.3,18900,1,5,0)
 ;;=5^L/T (Current) Anticoagulant Use
 ;;^UTILITY(U,$J,358.3,18900,2)
 ;;=^303459
 ;;^UTILITY(U,$J,358.3,18901,0)
 ;;=V58.62^^104^1102^22
 ;;^UTILITY(U,$J,358.3,18901,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,18901,1,2,0)
 ;;=2^V58.62
 ;;^UTILITY(U,$J,358.3,18901,1,5,0)
 ;;=5^L/T (Current) Antibiotics Use
 ;;^UTILITY(U,$J,358.3,18901,2)
 ;;=^321546
 ;;^UTILITY(U,$J,358.3,18902,0)
 ;;=V58.63^^104^1102^24
 ;;^UTILITY(U,$J,358.3,18902,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,18902,1,2,0)
 ;;=2^V58.63
 ;;^UTILITY(U,$J,358.3,18902,1,5,0)
 ;;=5^L/T (Current) Antiplts/Antithrmbtcs
 ;;^UTILITY(U,$J,358.3,18902,2)
 ;;=^329978
 ;;^UTILITY(U,$J,358.3,18903,0)
 ;;=V58.64^^104^1102^28
 ;;^UTILITY(U,$J,358.3,18903,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,18903,1,2,0)
 ;;=2^V58.64
 ;;^UTILITY(U,$J,358.3,18903,1,5,0)
 ;;=5^L/T (Current) NSAIDS Use
 ;;^UTILITY(U,$J,358.3,18903,2)
 ;;=^329979
 ;;^UTILITY(U,$J,358.3,18904,0)
 ;;=V58.65^^104^1102^30
 ;;^UTILITY(U,$J,358.3,18904,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,18904,1,2,0)
 ;;=2^V58.65
 ;;^UTILITY(U,$J,358.3,18904,1,5,0)
 ;;=5^L/T (Current) Steroids Use
 ;;^UTILITY(U,$J,358.3,18904,2)
 ;;=^329980
 ;;^UTILITY(U,$J,358.3,18905,0)
 ;;=V58.66^^104^1102^25
 ;;^UTILITY(U,$J,358.3,18905,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,18905,1,2,0)
 ;;=2^V58.66
 ;;^UTILITY(U,$J,358.3,18905,1,5,0)
 ;;=5^L/T (Current) Aspirin Use
 ;;^UTILITY(U,$J,358.3,18905,2)
 ;;=^331584
 ;;^UTILITY(U,$J,358.3,18906,0)
 ;;=V58.67^^104^1102^27
 ;;^UTILITY(U,$J,358.3,18906,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,18906,1,2,0)
 ;;=2^V58.67
 ;;^UTILITY(U,$J,358.3,18906,1,5,0)
 ;;=5^L/T (Current) Insulin Use
 ;;^UTILITY(U,$J,358.3,18906,2)
 ;;=^331585
 ;;^UTILITY(U,$J,358.3,18907,0)
 ;;=V58.68^^104^1102^26
